Arax Advisory Partners’s Definitive Healthcare DH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6K Buy
13,944
+13,923
+66,300% +$12.8K ﹤0.01% 4259
2026
Q1
$280 Buy
+21
New +$37 ﹤0.01% 3501
2025
Q4
Sell
-22,088
Closed -$89.7K 4192
2025
Q3
$89.7K Buy
+22,088
New +$88.2K ﹤0.01% 1574
2024
Q4
Sell
-197
Closed -$881 2505
2024
Q3
$881 Hold
197
﹤0.01% 2294
2024
Q2
$1.08K Buy
+197
New +$1.24K ﹤0.01% 2150

Other funds holding DH

Arax Advisory Partners's DH Position: Q2 2026 in Review

Arax Advisory Partners increased its Definitive Healthcare (DH) stake by 66,300% in Q2 2026, buying an estimated $12.8K and bringing the position to 13,944 shares worth $11.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4259.

Arax Advisory Partners first reported a position in DH in Q2 2024 and has held it in 5 quarters since. The position peaked at $89.7K in Q3 2025. 100 funds tracked by Wall St. Rank hold DH as of Q2 2026.

  • Arax Advisory Partners held 13,944 shares of Definitive Healthcare worth $11.6K as of Q2 2026.
  • Arax Advisory Partners bought 13,923 Definitive Healthcare shares in Q2 2026, an estimated $12.8K.
  • Definitive Healthcare made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4259 holding.
  • Arax Advisory Partners first reported a position in Definitive Healthcare in Q2 2024 and has held it in 5 quarters since.
  • Arax Advisory Partners's Definitive Healthcare position peaked at $89.7K in Q3 2025.
  • 100 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.